We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

108 hedge funds and large institutions have $366M invested in Cytokinetics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

591% more call options, than puts

Call options by funds: $4.32M | Put options by funds: $626K

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

13% more capital invested

Capital invested by funds: $323M → $366M (+$42.7M)

7% more funds holding

Funds holding: 101 → 108 (+7)

2.73% more ownership

Funds ownership: 65.48% → 68.21% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
35
Reduced
29
Closed
16
Calls
$4.32M
Puts
$626K
Net Calls
+$3.7M
Net Calls Change
+$3.76M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$35.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.34M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.91M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.13M
5
HCMT
Highland Capital Management (Texas)
Texas
+$2.51M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$6.91M
2
DCM
DAFNA Capital Management
California
-$2.56M
3
WA
Wasatch Advisors
Utah
-$2.09M
4
GC
Globeflex Capital
California
-$1.69M
5
CCMH
Cornerstone Capital Management Holdings
New York
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FIM
26
Freedom Investment Management
Connecticut
$1.76M -$215K -18,396 -12%
GCP
27
GSA Capital Partners
United Kingdom
$1.69M +$1.54M +131,502 New
PAI
28
Palo Alto Investors
California
$1.59M – – –
IIM
29
Ironwood Investment Management
Massachusetts
$1.52M -$38.1K -3,258 -3%
TCIM
30
TIAA CREF Investment Management
New York
$1.38M +$107K +9,162 +9%
Invesco
31
Invesco
Georgia
$1.28M +$999K +85,461 +592%
TC
32
TFS Capital
Pennsylvania
$1.23M +$1.12M +95,987 New
CAM
33
ClariVest Asset Management
California
$1.15M – – –
Allianz Asset Management
34
Allianz Asset Management
Germany
$1.09M +$987K +84,476 New
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$1.08M -$998K -85,395 -50%
Deutsche Bank
36
Deutsche Bank
Germany
$1.08M -$160K -13,711 -14%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.06M – – –
TCM
38
Timpani Capital Management
Wisconsin
$868K +$790K +67,551 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$857K -$36.2K -3,100 -4%
SIM
40
Spark Investment Management
New York
$844K +$768K +65,700 New
TI
41
Trexquant Investment
Connecticut
$802K +$729K +62,381 New
TA
42
Teachers Advisors
New York
$775K +$82.4K +7,048 +13%
Goldman Sachs
43
Goldman Sachs
New York
$661K -$234K -20,061 -28%
Ohio Public Employees Retirement System (OPERS)
44
Ohio Public Employees Retirement System (OPERS)
Ohio
$656K – – –
GAM
45
Gotham Asset Management
New York
$641K +$583K +49,907 New
Simplex Trading
46
Simplex Trading
Illinois
$619K +$407K +34,828 +261%
PCM
47
Piermont Capital Management
Missouri
$612K +$557K +47,618 New
SAM
48
Shell Asset Management
Netherlands
$551K +$501K +42,875 New
AL
49
Airain Ltd
Guernsey
$536K +$233K +19,948 +92%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$520K -$104K -8,900 -18%
1
2
3 4 5

CYTK Hedge Fund Activity: Q1 2017 in Review

108 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2017, worth a combined $366M — up 13% from $323M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CYTK positions and 16 closed out — a net gain of 12 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $35.5M. The largest seller was BVF Inc, cutting an estimated $6.91M.

  • 108 institutional investors held Cytokinetics (CYTK) as of Q1 2017, up from 101 in Q4 2016.
  • Funds reported $366M of Cytokinetics stock for Q1 2017, up 13% quarter-over-quarter.
  • 28 funds opened new Cytokinetics positions in Q1 2017 and 16 closed out, a net change of +12 holders.
  • The largest Cytokinetics buyer in Q1 2017 was BlackRock, an estimated $35.5M added.
  • The largest Cytokinetics seller in Q1 2017 was BVF Inc, an estimated $6.91M sold.

Based on aggregated 13F filings for Q1 2017.